Clinical Trial Update: A Study Evaluating HBM9036 Efficacy and Safety on Moderate to Severe Dry Eye [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating HBM9036 for moderate to severe dry eye has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye

Drugs mentioned

• HBM9036

Snippet

Sponsor: Harbour BioMed (Guangzhou) Co. Ltd. | Conditions: Dry Eye | Phase 3 | Status: COMPLETED